Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during β-cell carcinogenesis

Cancer Research

Volumn 62, Issue 2, 2002, Pages 603-608

  Gannon, Grainne ^a   Christofori, Gerhard ^a   Mandriota, Stefano J ^b   Cui, Lin ^b   Baetens, Danielle ^b   Pepper, Michael S ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CARCINOGENESIS; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; METASTASIS; MOUSE; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; TRANSGENIC MOUSE; TUMOR VASCULARIZATION;

ANIMALS; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; INSULINOMA; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0037081097     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Vascular endothelial growth factor: Molecular and biological aspects
2. Vascular endothelial growth factor (VEGF) and its receptors
3. The splice variants of vascular endothelial growth factor (VEGF) and their receptors
4. Signaling via vascular endothelial growth factor receptors
5. Current biology of Vegf-B and Vegf-C
6. The vascular endothelial growth factor family: Signalling for vascular development
7. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
8. Clinical applications of angiogenic growth factors and their inhibitors
9. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis?
10. VEGF: An update on biological and therapeutic aspects
11. Angiogenesis in cancer and other diseases
12. Tumor angiogenesis: Past, present and the near future
13. Tumoral vascularity as a prognostic factor in cancer
14. Halting angiogenesis suppresses carcinoma cell invasion
15. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts
16. Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
17. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
18. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
19. Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets
20. A causal role for E-cadherin in the transition from adenoma to carcinoma
21. Induction of angiogenesis during the transition from hyperplasia to neoplasia
22. Vascular endothelial growth factor and its receptors, fit-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis
23. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
24. Fibroblast growth factors are required for efficient tumor angiogenesis
25. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
26. The rise and fall of apoptosis during multistage tumorigenesis: Down- modulation contributes to tumor progression from angiogenic progenitors
27. Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier
28. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
29. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells
30. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression